Sumei Lu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Thyroid Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
Papers in
-
- Circular RNAs in diseases 4
- Peroxisome Proliferator-Activated Receptors 4
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Co-authors
- Wanshan Ma (11 shared papers)Haibo Wang (6 shared papers)Xiangdong Wang (3 shared papers)Yanhong Xu (1 shared paper)Yong‐Hui Zheng (1 shared paper)Jiaolin Zheng (1 shared paper)Yuchao Zhang (4 shared papers)Jicui Chen (3 shared papers)
- Journals
- Lipids in Health and Disease (4 papers)Frontiers in Bioengineering and Biotechnology (2 papers)Cellular Physiology and Biochemistry (2 papers)Diabetes Obesity and Metabolism (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Sumei Lu
28 papers receiving 496 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 129
- Endocrinology, Diabetes and Metabolism 88
- Molecular Medicine 24
- Endocrine and Autonomic Systems 28
- Molecular Biology 268
Countries citing papers authored by Sumei Lu
This map shows the geographic impact of Sumei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumei Lu more than expected).
Fields of papers citing papers by Sumei Lu
This network shows the impact of papers produced by Sumei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumei Lu. The network helps show where Sumei Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumei Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 85 | |
| 2 | 2017 | 76 | |
| 3 | 2019 | 48 | |
| 4 | 2017 | 25 | |
| 5 | 2017 | 25 | |
| 6 | 2021 | 25 | |
| 7 | 2017 | 21 | |
| 8 | 2009 | 21 | |
| 9 | 2014 | 20 | |
| 10 | 2016 | 19 | |
| 11 | 2021 | 18 | |
| 12 | 2022 | 16 | |
| 13 | 2011 | 14 | |
| 14 | 2016 | 14 | |
| 15 | 2010 | 14 | |
| 16 | 2014 | 14 | |
| 17 | 2018 | 11 | |
| 18 | 2012 | 10 | |
| 19 | 2021 | 6 | |
| 20 | 2022 | 6 |
About Sumei Lu
Sumei Lu is a scholar working on Molecular Biology, Cancer Research, Physiology, Oncology and Cardiology and Cardiovascular Medicine, having authored 30 papers that have together received 506 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Adipose Tissue and Metabolism (6 papers), Circular RNAs in diseases (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), RNA Interference and Gene Delivery (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (129 citations), Endocrinology, Diabetes and Metabolism (88 citations), Molecular Medicine (24 citations), Endocrine and Autonomic Systems (28 citations) and Molecular Biology (268 citations). Sumei Lu has collaborated with scholars based in China and United States. Frequent co-authors include Wanshan Ma, Haibo Wang, Xiangdong Wang, Yanhong Xu, Yong‐Hui Zheng, Jiaolin Zheng, Yuchao Zhang, Jicui Chen, Chen Zong and Yuchang Fu. Their work appears in journals such as Lipids in Health and Disease, Frontiers in Bioengineering and Biotechnology, Cellular Physiology and Biochemistry, Diabetes Obesity and Metabolism and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.